| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-020-05504-0 |
| P698 | PubMed publication ID | 32221694 |
| P50 | author | Cigdem Sahbaz | Q89541232 |
| Sinan Guloksuz | Q98923891 | ||
| P2093 | author name string | Fikrettin Sahin | |
| Tunc Akkoc | |||
| Ayse Kurtulmus | |||
| Ismet Kırpınar | |||
| Muazzez Gokalp | |||
| Noushin Zibandey | |||
| Yazgul Duran | |||
| P2860 | cites work | Methodological Issues in Cytokine Measurement in Schizophrenia | Q26751839 |
| Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
| Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity | Q28261030 | ||
| Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects | Q28657600 | ||
| Regulatory T cells and immune tolerance | Q29616864 | ||
| Molecular antagonism and plasticity of regulatory and inflammatory T cell programs | Q29619478 | ||
| Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms | Q33292693 | ||
| Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection | Q33624096 | ||
| Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications | Q34323034 | ||
| Activation and inhibition of lymphocytes by costimulation | Q34517906 | ||
| Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells | Q36156864 | ||
| Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects | Q37275549 | ||
| Anti-inflammatory signaling in schizophrenia | Q37888032 | ||
| Neuroinflammation and white matter pathology in schizophrenia: systematic review. | Q38221829 | ||
| Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study | Q38435398 | ||
| Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions | Q38809444 | ||
| Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects. | Q38957566 | ||
| Psychosis: an autoimmune disease? | Q39432877 | ||
| Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia | Q42084606 | ||
| Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia | Q42171152 | ||
| The Maintenance of Telomere Length in CD28+ T Cells During T Lymphocyte Stimulation | Q42339232 | ||
| Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity | Q43182337 | ||
| Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway | Q45329206 | ||
| Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder | Q45790764 | ||
| Differential effects on T-cell function following exposure to serum from schizophrenia smokers | Q46252490 | ||
| Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia. | Q47987802 | ||
| A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression | Q48063321 | ||
| Effects of depression on the cytokine profile in drug naïve first-episode psychosis. | Q48107320 | ||
| Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. | Q50743494 | ||
| Decreased T cellular immune response in schizophrenic patients. | Q51282803 | ||
| Impact of antipsychotics on cytokine production in-vitro. | Q51461858 | ||
| Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. | Q51997055 | ||
| A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis? | Q52642064 | ||
| Neuroprotective activities of regulatory T cells. | Q54967358 | ||
| Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients | Q60649880 | ||
| Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells. | Q64897408 | ||
| T cell stimulation and expansion using anti-CD3/CD28 beads | Q73197893 | ||
| Interleukin-17 Alteration in First-Episode Psychosis: A Meta-Analysis | Q88208121 | ||
| The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders | Q88761647 | ||
| Increased circulating regulatory T cells in medicated people with schizophrenia | Q91340923 | ||
| P921 | main subject | schizophrenia | Q41112 |
| P577 | publication date | 2020-03-27 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia |
| Q103803509 | A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis | cites work | P2860 |
Search more.